Anafranil: Restoring Balance in Treatment-Resistant OCD
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.89 | $53.22 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $79.82 $72.29 (9%) | 🛒 Add to cart |
| 120 | $0.76 | $106.43 $91.37 (14%) | 🛒 Add to cart |
| 180 | $0.72 | $159.65 $129.53 (19%) | 🛒 Add to cart |
| 270 | $0.69 | $239.47 $185.75 (22%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $319.30 $242.99 (24%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.87 | $56.23 (0%) | 🛒 Add to cart |
| 60 | $1.47 | $112.46 $88.36 (21%) | 🛒 Add to cart |
| 90 | $1.35 | $168.68 $121.49 (28%) | 🛒 Add to cart |
| 120 | $1.28 | $224.91 $153.62 (32%) | 🛒 Add to cart |
| 180 | $1.22 | $337.37 $219.89 (35%) | 🛒 Add to cart |
| 270 | $1.17 | $506.05 $316.28 (37%) | 🛒 Add to cart |
| 360 | $1.15
Best per pill | $674.74 $414.68 (39%) | 🛒 Add to cart |
| Product dosage: 75mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.61 | $78.32 (0%) | 🛒 Add to cart |
| 60 | $2.09 | $156.64 $125.51 (20%) | 🛒 Add to cart |
| 90 | $1.92 | $234.95 $172.70 (26%) | 🛒 Add to cart |
| 120 | $1.84 | $313.27 $220.90 (29%) | 🛒 Add to cart |
| 180 | $1.76 | $469.91 $316.28 (33%) | 🛒 Add to cart |
| 270 | $1.70
Best per pill | $704.86 $458.86 (35%) | 🛒 Add to cart |
Synonyms | |||
Anafranil (clomipramine hydrochloride) is a tricyclic antidepressant (TCA) with potent serotonin reuptake inhibition, approved for the treatment of obsessive-compulsive disorder (OCD). It is recognized for its efficacy in cases where first-line treatments have proven insufficient. By modulating neurotransmitter activity in the central nervous system, Anafranil helps reduce the frequency and intensity of obsessive thoughts and compulsive behaviors. Its well-established pharmacokinetic profile and decades of clinical use make it a cornerstone in psychopharmacology for severe OCD and related anxiety conditions.
Features
- Active ingredient: Clomipramine hydrochloride
- Available in 10 mg, 25 mg, and 50 mg tablets
- High affinity for serotonin reuptake inhibition
- Also exhibits noradrenergic reuptake blockade
- Long half-life allowing for once-daily dosing in maintenance phase
- FDA-approved for obsessive-compulsive disorder
- Used off-label for panic disorder, depression, and chronic pain
Benefits
- Significantly reduces obsessive thoughts and compulsive rituals in OCD
- Improves overall daily functioning and quality of life
- Provides relief from comorbid depressive and anxiety symptoms
- Offers a therapeutic option for treatment-resistant cases
- Long-term efficacy supported by extensive clinical data
- Flexible dosing allows for individualized treatment plans
Common use
Anafranil is primarily indicated for the management of obsessive-compulsive disorder in adults and children aged 10 years and older. It is considered when selective serotonin reuptake inhibitors (SSRIs) provide inadequate response or cannot be tolerated. Off-label applications include major depressive disorder, panic disorder, cataplexy associated with narcolepsy, and chronic neuropathic pain syndromes. Its use requires careful patient selection and ongoing monitoring due to its side effect profile and potential for serious adverse reactions.
Dosage and direction
Initial dosage for adults typically begins at 25 mg daily, gradually increased to 100 mg during the first two weeks. Target therapeutic dosage ranges from 150 mg to 250 mg daily, divided into two or three doses. Maximum recommended dose is 300 mg daily. For elderly patients or those with hepatic impairment, initial dose should not exceed 20-30 mg daily, with gradual titration. Maintenance therapy usually continues for at least one year after satisfactory response. Always take with food to minimize gastrointestinal discomfort. Do not crush or chew tablets; swallow whole with water.
Precautions
Regular monitoring of blood pressure and heart rate is essential due to potential orthostatic hypotension and tachycardia. Baseline and periodic ECG monitoring recommended, especially in patients with cardiac history or those over 40 years. Use with caution in patients with glaucoma, urinary retention, or seizure disorders. May impair mental or physical abilities required for hazardous tasks. Avoid abrupt discontinuation; taper gradually over at least 1-2 weeks. Pregnancy Category C: use only if potential benefit justifies potential risk to fetus.
Contraindications
Hypersensitivity to clomipramine or other tricyclic antidepressants. Concurrent use with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy. During the acute recovery phase after myocardial infarction. Patients with uncontrolled narrow-angle glaucoma. Severe liver impairment. History of urinary retention. Concomitant use with drugs that prolong QT interval.
Possible side effects
Common (≥1%): dry mouth, constipation, blurred vision, dizziness, drowsiness, weight gain, increased sweating, nausea, fatigue. Less common: orthostatic hypotension, tachycardia, sexual dysfunction, tremors, headache. Serious: seizures, serotonin syndrome, neuroleptic malignant syndrome, agranulocytosis, suicidal ideation (particularly in young adults), hepatitis, cardiac arrhythmias. Most side effects are dose-dependent and may diminish with continued therapy.
Drug interaction
MAOIs: risk of serotonin syndrome. SSRIs/SNRIs: increased serotonergic effects. CYP2D6 inhibitors (quinidine, fluoxetine): increased clomipramine levels. Anticholinergic drugs: enhanced anticholinergic effects. Sympathomimetics: increased cardiovascular effects. CNS depressants: additive sedation. Warfarin: may potentiate anticoagulant effect. Antihypertensives: may reduce efficacy. Thyroid medications: may enhance arrhythmogenic potential.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. If regular dosing schedule is frequently forgotten, consider using a pill organizer or setting reminders. Contact healthcare provider if multiple doses are missed, as withdrawal symptoms may occur.
Overdose
Symptoms may include severe drowsiness, agitation, confusion, hallucinations, tachycardia, hypotension, seizures, coma, and cardiac arrhythmias. QT prolongation and torsades de pointes may occur. Management includes gastric lavage if presented early, activated charcoal, and supportive care with continuous ECG monitoring. Physostigmine may be considered for central anticholinergic effects. There is no specific antidote; treatment is symptomatic and supportive.
Storage
Store at room temperature (15-30°C or 59-86°F) in original container. Protect from light and moisture. Keep tightly closed. Do not store in bathroom or near sink. Keep out of reach of children and pets. Do not use after expiration date printed on packaging. Dispose of unused medication through take-back programs or according to local regulations.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any medication regimen. Individual response to medication may vary. Proper diagnosis and monitoring by a physician are essential for safe and effective treatment. Not all possible uses, interactions, or precautions are listed here.
Reviews
Clinical studies demonstrate Anafranil’s significant efficacy in OCD treatment, with response rates of 40-60% in treatment-resistant cases. Many patients report substantial improvement in quality of life after 8-12 weeks of therapy. However, side effects remain a common reason for discontinuation. Long-term studies show maintained efficacy with appropriate dosing adjustments. Patient satisfaction correlates with adequate pre-treatment education and careful management of expectations regarding side effects and timeline of response.